+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Carboplatin"

From
Ovarian Cancer Drugs - Global Strategic Business Report - Product Thumbnail Image

Ovarian Cancer Drugs - Global Strategic Business Report

  • Report
  • April 2025
  • 250 Pages
  • Global
From
Lung Cancer Drugs Market Report 2025 - Product Thumbnail Image

Lung Cancer Drugs Market Report 2025

  • Report
  • April 2025
  • 175 Pages
  • Global
From
Pontine Glioma Drugs Market Report 2025 - Product Thumbnail Image

Pontine Glioma Drugs Market Report 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
Small Cell Lung Cancer Therapeutics Market Report 2025 - Product Thumbnail Image

Small Cell Lung Cancer Therapeutics Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Non-Small Cell Lung Cancer (NSCLC) Market Report 2025 - Product Thumbnail Image

Non-Small Cell Lung Cancer (NSCLC) Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Ovarian Cancer Drugs Market Report 2025 - Product Thumbnail Image

Ovarian Cancer Drugs Market Report 2025

  • Report
  • March 2025
  • 175 Pages
  • Global
From
Ovarian Cancer Pipeline Analysis Report - Product Thumbnail Image

Ovarian Cancer Pipeline Analysis Report

  • Report
  • August 2024
  • 150 Pages
  • Global
From
From
From
Glioblastoma - Pipeline Insight, 2024 - Product Thumbnail Image

Glioblastoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 440 Pages
  • Global
From
Extensive-Stage Small Cell Lung Cancer (ESCLC) - Pipeline Insight, 2024 - Product Thumbnail Image

Extensive-Stage Small Cell Lung Cancer (ESCLC) - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
High-Grade Glioma - Pipeline Insight, 2024 - Product Thumbnail Image

High-Grade Glioma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 200 Pages
  • Global
US Glioma - Market Insight, Epidemiology And Market Forecast - 2032 - Product Thumbnail Image

US Glioma - Market Insight, Epidemiology And Market Forecast - 2032

  • Report
  • April 2023
  • 200 Pages
  • United States
From
Gemcitabine HCL Market Report and Forecast 2023-2031 - Product Thumbnail Image

Gemcitabine HCL Market Report and Forecast 2023-2031

  • Report
  • May 2023
  • 147 Pages
  • Global
From
Advanced ovarian cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Advanced ovarian cancer - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 210 Pages
  • Global
From
Loading Indicator

Carboplatin is a chemotherapy drug used to treat lung cancer. It is a platinum-based drug, which works by interfering with the growth of cancer cells. It is often used in combination with other drugs, such as paclitaxel, to treat non-small cell lung cancer. Carboplatin is also used to treat other types of cancer, such as ovarian and bladder cancer. Carboplatin is generally well-tolerated, with fewer side effects than other chemotherapy drugs. Common side effects include nausea, vomiting, and hair loss. It is important to note that Carboplatin can cause serious side effects, such as kidney damage and hearing loss. The Carboplatin market is highly competitive, with many companies offering generic versions of the drug. Some of the major players in the market include Pfizer, Bristol-Myers Squibb, Merck, and AstraZeneca. Other companies, such as Teva Pharmaceuticals and Mylan, also offer generic versions of Carboplatin. Show Less Read more